Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $311.59 million. The enterprise value is $251.41 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABEO has 48.53 million shares outstanding. The number of shares has increased by 94.57% in one year.
| Current Share Class | 48.53M |
| Shares Outstanding | 48.53M |
| Shares Change (YoY) | +94.57% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | 6.61% |
| Owned by Institutions (%) | 45.73% |
| Float | 35.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.59 |
| P/TBV Ratio | 7.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.58.
| Current Ratio | 4.90 |
| Quick Ratio | 4.77 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.36 |
Financial Efficiency
Return on equity (ROE) is -271.78% and return on invested capital (ROIC) is -109.23%.
| Return on Equity (ROE) | -271.78% |
| Return on Assets (ROA) | -49.95% |
| Return on Invested Capital (ROIC) | -109.23% |
| Return on Capital Employed (ROCE) | -85.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$324,890 |
| Employee Count | 136 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.91% in the last 52 weeks. The beta is 1.68, so ABEO's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +45.91% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 5.63 |
| Relative Strength Index (RSI) | 62.14 |
| Average Volume (20 Days) | 3,344,502 |
Short Selling Information
The latest short interest is 5.45 million, so 11.24% of the outstanding shares have been sold short.
| Short Interest | 5.45M |
| Short Previous Month | 2.76M |
| Short % of Shares Out | 11.24% |
| Short % of Float | 15.39% |
| Short Ratio (days to cover) | 2.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | -34.36M |
| Operating Income | -69.61M |
| Pretax Income | -76.66M |
| Net Income | -44.19M |
| EBITDA | -67.56M |
| EBIT | -69.61M |
| Earnings Per Share (EPS) | -$0.95 |
Full Income StatementBalance Sheet
The company has $84.16 million in cash and $23.98 million in debt, giving a net cash position of $60.18 million or $1.24 per share.
| Cash & Cash Equivalents | 84.16M |
| Total Debt | 23.98M |
| Net Cash | 60.18M |
| Net Cash Per Share | $1.24 |
| Equity (Book Value) | 41.40M |
| Book Value Per Share | 0.85 |
| Working Capital | 70.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$59.88 million and capital expenditures -$3.12 million, giving a free cash flow of -$63.00 million.
| Operating Cash Flow | -59.88M |
| Capital Expenditures | -3.12M |
| Free Cash Flow | -63.00M |
| FCF Per Share | -$1.30 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |